Search Results - "Comisar, Wendy"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: A combined computational and experimental approach by Comisar, Wendy A, Kazmers, Nikolas H, Mooney, David J, Linderman, Jennifer J

    Published in Biomaterials (01-10-2007)
    “…Abstract The adhesion ligand arginine–glycine–aspartic acid (RGD) has been coupled to various materials to be used as tissue culture matrices or cell…”
    Get full text
    Journal Article
  2. 2

    A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients with Advanced Cancer by Munster, Pamela N, Rubin, Eric H, Van Belle, Simon, Friedman, Evan, Patterson, Jaclyn K, Van Dyck, Kristien, Li, Xiadong, Comisar, Wendy, Chodakewitz, Jeffery A, Wagner, John A, Iwamoto, Marian

    Published in Clinical cancer research (15-11-2009)
    “…Purpose: This dedicated QTc phase I study, conducted in advanced-stage cancer patients, assessed the effect of a single supratherapeutic dose (800 mg) of…”
    Get full text
    Journal Article
  3. 3

    Multi-scale modeling to predict ligand presentation within RGD nanopatterned hydrogels by Comisar, Wendy A., Hsiong, Susan X., Kong, Hyun-Joon, Mooney, David J., Linderman, Jennifer J.

    Published in Biomaterials (01-04-2006)
    “…The adhesion ligand RGD has been coupled to various materials to be used as tissue culture matrices or cell transplantation vehicles, and recent studies…”
    Get full text
    Journal Article
  4. 4

    Nanoscale Adhesion Ligand Organization Regulates Osteoblast Proliferation and Differentiation by Lee, Kuen Yong, Alsberg, Eben, Hsiong, Susan, Comisar, Wendy, Linderman, Jennifer, Ziff, Robert, Mooney, David

    Published in Nano letters (01-08-2004)
    “…It was hypothesized that nanoscale adhesion ligand spacing regulates cell adhesion, proliferation, and differentiation, and that this control can be decoupled…”
    Get full text
    Journal Article
  5. 5

    A semimechanistic model of the time‐course of release of PTH into plasma following administration of the calcilytic JTT‐305/MK‐5442 in humans by Cabal, Antonio, Mehta, Khamir, Ross, David S, Shrestha, Rajiv P, Comisar, Wendy, Denker, Andrew, Pai, Sudhakar M, Ishikawa, Tomohiro

    Published in Journal of bone and mineral research (01-08-2013)
    “…ABSTRACT JTT‐305/MK‐5442 is a calcium‐sensing receptor (CaSR) allosteric antagonist being investigated for the treatment of osteoporosis. JTT‐305/MK‐5442 binds…”
    Get full text
    Journal Article
  6. 6

    Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants by Migoya, Elizabeth M., Mistry, Goutam C., Stone, Julie A., Comisar, Wendy, Sun, Peng, Norcross, Alisha, Bi, Sheng, Winchell, Gregory A., Ghosh, Kalyan, Uemera, Naoto, Deutsch, Paul J., Wagner, John A.

    Published in Journal of clinical pharmacology (01-02-2011)
    “…Caspofungin was the first in a new class of antifungal agents (echinocandins) indicated for the treatment of primary and refractory fungal infections. Higher…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals by Zhu, Li, Butterton, Joan, Persson, Anna, Stonier, Michele, Comisar, Wendy, Panebianco, Deborah, Breidinger, Sheila, Zhang, Jenny, Bertz, Richard

    Published in Antiviral therapy (01-01-2010)
    “…Atazanavir plus raltegravir 300/400 mg twice daily is being explored as a ritonavir- and nucleoside-sparing treatment strategy. The pharmacokinetics and safety…”
    Get more information
    Journal Article
  8. 8

    Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasis by Comisar, Wendy, Sun, Peng, Li, Susan, Sable, Carole, Schwartz, Michael, Bi, Sheng, Chow, Joseph, Ngai, Angela, Winchell, Gregory, Kartsonis, Nicholas, Stone, Julie

    Published in Clinical pharmacology in drug development (01-01-2014)
    “…Caspofungin is an echinocandin antifungal agent administered once daily as an intravenous infusion. Relationships between caspofungin exposure and clinical…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Controlling osteogenesis through nanoscale organization of adhesion ligand in alginate hydrogels by Comisar, Wendy Ankrom

    Published 01-01-2007
    “…The adhesion ligand RGD (arginine-glycine-aspartic acid) has been coupled to various materials to be used as tissue culture matrices or cell transplantation…”
    Get full text
    Dissertation